Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Baddley

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2021
Coronavirus Disease 2019-associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?John W Baddley
Future Microbiology|February 12, 2009
Pinpointing prognostic indicators of fungal infections in transplant patientsJohn W Baddley
Medical Mycology|August 20, 2010
Clinical risk factors for invasive aspergillosisJohn W Baddley
Current Fungal Infection Reports|September 30, 2017
Prevention of Invasive Aspergillosis in High-Risk Patients: Universal Versus Preemptive, Targeted TreatmentJohn W Baddley, Senu Apewokin
Seminars in Respiratory and Critical Care Medicine|January 31, 2020
CryptococcosisSofia Zavala, John W Baddley
The Lancet. Infectious Diseases|September 26, 2014
Mollaret's meningitisZaw Min, John W Baddley
Current Opinion in Pulmonary Medicine|April 9, 2009
Cryptococcal lung diseaseRhett M Shirley, John W Baddley
Rheumatic Diseases Clinics of North America|November 29, 2016
Opportunistic Infections in Biological Therapy, Risk and PreventionPaul A Bryant, John W Baddley
Drugs|July 22, 2005
Antifungal combination therapy: clinical potentialJohn W Baddley, Peter G Pappas
Clinics in Laboratory Medicine|August 25, 2004
Emerging fungal resistanceJohn W Baddley, Stephen A Moser
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2021
Coronavirus Disease 2019-associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?John W Baddley
Future Microbiology|February 12, 2009
Pinpointing prognostic indicators of fungal infections in transplant patientsJohn W Baddley
Medical Mycology|August 20, 2010
Clinical risk factors for invasive aspergillosisJohn W Baddley
Current Fungal Infection Reports|September 30, 2017
Prevention of Invasive Aspergillosis in High-Risk Patients: Universal Versus Preemptive, Targeted TreatmentJohn W Baddley, Senu Apewokin
Seminars in Respiratory and Critical Care Medicine|January 31, 2020
CryptococcosisSofia Zavala, John W Baddley
The Lancet. Infectious Diseases|September 26, 2014
Mollaret's meningitisZaw Min, John W Baddley
Current Opinion in Pulmonary Medicine|April 9, 2009
Cryptococcal lung diseaseRhett M Shirley, John W Baddley
Rheumatic Diseases Clinics of North America|November 29, 2016
Opportunistic Infections in Biological Therapy, Risk and PreventionPaul A Bryant, John W Baddley
Drugs|July 22, 2005
Antifungal combination therapy: clinical potentialJohn W Baddley, Peter G Pappas
Clinics in Laboratory Medicine|August 25, 2004
Emerging fungal resistanceJohn W Baddley, Stephen A Moser
Pageof 15